open access

Vol 58, No 4 (2020)
Brief communication
Submitted: 2020-08-26
Accepted: 2020-12-02
Published online: 2020-12-21
Get Citation

Urothelial cancer of the prostate gland. Immunohistochemical analysis of two cases of rare canine cancer

Rafal Ciaputa1, Valeria Grieco2, Izabela Janus1, Malgorzata Kandefer-Gola1, Piotr Dziegiel34, Marcin Nowak1
DOI: 10.5603/FHC.a2020.0027
·
Pubmed: 33346908
·
Folia Histochem Cytobiol 2020;58(4):272-277.
Affiliations
  1. Department of Pathology, Division of Pathomorphology and Veterinary Forensics, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, C. K. Norwida 31, 50-375 Wroclaw, Poland
  2. Department of Veterinary Medicine, Università degli Studi di Milano, G. Celoria 10, 20133 Milan, Italy
  3. Department of Histology and Embryology, Wroclaw Medical University. Department of Physiotherapy, Wroclaw University School of Physical Education., T. Chałubińskiego 6a, 50-368 Wroclaw, Poland
  4. Department of Physiotherapy, Wroclaw University School of Physical Education, Wroclaw, Poland

open access

Vol 58, No 4 (2020)
Short Communication
Submitted: 2020-08-26
Accepted: 2020-12-02
Published online: 2020-12-21

Abstract

Introduction. The study aimed to diagnose urothelial cancer of prostate gland (UCPG) in dogs as the primary focus and in its metastasis based on the expression of specific proteins used in immunohistochemical diagnosis of prostate cancer in men.

Material and methods. The study was carried out on specimens collected during a post-mortem examination from macroscopic lesions of the prostate glands from two dogs. The immunoexpression of the following proteins was verified: prostate-specific antigen (PSA), high molecular weight cytokeratins (HMWCK), cytokeratin 7 and 20 (CK-7,-20), E-cadherin, von Willebrand factor, cyclooxygenase-2 (COX-2), microsomal PGE2-1 synthase (mPGES-1) and component of the minichromosome 7 maintenance complex (MCM7).

Results. All markers, except for PSA, were expressed both at the primary tumour site and in the metastasis.

Conclusions. The immunohistochemical approach was more useful for the diagnosis of UCPG in dog than typical histopathological staining methods because it allowed for precise determination of features, type and grade of the tumour that may affect its early detection and treatment.

Abstract

Introduction. The study aimed to diagnose urothelial cancer of prostate gland (UCPG) in dogs as the primary focus and in its metastasis based on the expression of specific proteins used in immunohistochemical diagnosis of prostate cancer in men.

Material and methods. The study was carried out on specimens collected during a post-mortem examination from macroscopic lesions of the prostate glands from two dogs. The immunoexpression of the following proteins was verified: prostate-specific antigen (PSA), high molecular weight cytokeratins (HMWCK), cytokeratin 7 and 20 (CK-7,-20), E-cadherin, von Willebrand factor, cyclooxygenase-2 (COX-2), microsomal PGE2-1 synthase (mPGES-1) and component of the minichromosome 7 maintenance complex (MCM7).

Results. All markers, except for PSA, were expressed both at the primary tumour site and in the metastasis.

Conclusions. The immunohistochemical approach was more useful for the diagnosis of UCPG in dog than typical histopathological staining methods because it allowed for precise determination of features, type and grade of the tumour that may affect its early detection and treatment.

Get Citation

Keywords

canine; prostate; urothelial cancer; metastasis; cell markers; IHC

About this article
Title

Urothelial cancer of the prostate gland. Immunohistochemical analysis of two cases of rare canine cancer

Journal

Folia Histochemica et Cytobiologica

Issue

Vol 58, No 4 (2020)

Article type

Brief communication

Pages

272-277

Published online

2020-12-21

DOI

10.5603/FHC.a2020.0027

Pubmed

33346908

Bibliographic record

Folia Histochem Cytobiol 2020;58(4):272-277.

Keywords

canine
prostate
urothelial cancer
metastasis
cell markers
IHC

Authors

Rafal Ciaputa
Valeria Grieco
Izabela Janus
Malgorzata Kandefer-Gola
Piotr Dziegiel
Marcin Nowak

References (10)
  1. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer. 1997; 80(7): 1273–1283, doi: 10.1002/(SICI)1097-0142(19971001)80:7<1273:AID-CNCR13>3.0.CO;2-4.
  2. Waters DJ, Bostwick DG, Waters DJ, et al. Prostatic intraepithelial neoplasia occurs spontaneously in the canine prostate. J Urol. 1997; 157(2): 713–716, doi: 10.1002/(sici)1097-0045(19970201)30:2<92:aid-pros4>3.0.co;2-m.
  3. Waters D, Sakr W, Hayden D, et al. Workgroup 4: Spontaneous prostate carcinoma in dogs and nonhuman primates. The Prostate. 1998; 36(1): 64–67, doi: 10.1002/(sici)1097-0045(19980615)36:1<64::aid-pros12>3.0.co;2-g.
  4. Cornell KK, Bostwick DG, Cooley DM, et al. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: a retrospective analysis of 76 cases. Prostate. 2000; 45(2): 173–183, doi: 10.1002/1097-0045(20001001)45:2<173::aid-pros12>3.0.co;2-r.
  5. Lai CL, van den Ham R, van Leenders G, et al. Histopathological and immunohistochemical characterization of canine prostate cancer. Prostate. 2008; 68(5): 477–488.
  6. Kennedy PC, Cullen JM, Edwards JF, et al. Histological Classification of Tumors of the Genital System of Domestic Animals:Tumors of Accessory Reproductive Organs. 2nd edn. World Health Organization Animals. Armed Forces Institute of Pathology, Washington, USA. ; 1998: 53.
  7. Brouckaert O, Paridaens R, Floris G, et al. A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative. Ann Oncol. 2013; 24(1): 47–53.
  8. Ciaputa R. Immunohistochemical and Histological Features of a Spontaneous Leydig Cell Tumour in a Rat. Pakistan Veterinary Journal. 2019; 39(04): 603–605.
  9. Kandefer-Gola M, Nowak M, Ciaputa R, et al. Usefulness of immunohistochemical indicators for diagnosis and prognosis of poorly differentiated tumours. J Vet Res. 2016; 60(3): 323–330.
  10. Finetti F, Terzuoli E, Giachetti A, et al. mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity. Endocr Relat Cancer. 2015; 22(4): 665–678.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl